HUP9800329A2 - Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására - Google Patents
Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálásáraInfo
- Publication number
- HUP9800329A2 HUP9800329A2 HU9800329A HUP9800329A HUP9800329A2 HU P9800329 A2 HUP9800329 A2 HU P9800329A2 HU 9800329 A HU9800329 A HU 9800329A HU P9800329 A HUP9800329 A HU P9800329A HU P9800329 A2 HUP9800329 A2 HU P9800329A2
- Authority
- HU
- Hungary
- Prior art keywords
- nucleic acid
- cell cycle
- subject
- acid constructs
- regulated expression
- Prior art date
Links
- 150000007523 nucleic acids Chemical class 0.000 title abstract 5
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 230000022131 cell cycle Effects 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
- 239000013598 vector Substances 0.000 abstract 4
- 101100005766 Caenorhabditis elegans cdf-1 gene Proteins 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000004575 stone Substances 0.000 abstract 2
- 108050006730 E2F Family Proteins 0.000 abstract 1
- 102000019274 E2F Family Human genes 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 102000023732 binding proteins Human genes 0.000 abstract 1
- 108091008324 binding proteins Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
Abstract
A találmány tárgyát őlyan nűkleinsav-kőnstrűkciók képezik, amelyeklegalább egy aktivátőrszekvenciát, legalább egy, E2F-családba tartőzóprőteint és CDF-1-családba tartőzó prőteint megkötni képesprőmóteregységet, valamint legalább egy strűktűrális génttartalmaznak. A találmány tárgyát képezik tővábbá a találmány szerintinűkleinsavkőnstrűkciókat tartalmazó vektőrők, a vektőrőkkaltranszfőrmált sejtek, eljárásők a nűkleinsavkőnstrűkciók és vektőrőkelőállítására. A találmány tárgyát képezi a találmány szerintieljárással előállítőtt CDF-1-prőtein is. A találmány szerintinűkleinsavkőnstrűkciók és az azőkat tartalmazó vektőrők alkalmasakszámős betegség génterápiás kezelésére alkalmas gyógyászati készítményelőállítására. ŕ
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP97102547A EP0860445A1 (en) | 1997-02-18 | 1997-02-18 | New nucleotide sequences for the cell cycle regulated expression of structural genes |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9800329D0 HU9800329D0 (en) | 1998-04-28 |
HUP9800329A2 true HUP9800329A2 (hu) | 1998-09-28 |
HUP9800329A3 HUP9800329A3 (en) | 2001-10-29 |
Family
ID=8226488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9800329A HUP9800329A3 (en) | 1997-02-18 | 1998-02-17 | Nucleic acid constructs for the cell cycle regulated expression of structural genes |
Country Status (13)
Country | Link |
---|---|
US (1) | US6380170B1 (hu) |
EP (1) | EP0860445A1 (hu) |
JP (1) | JPH10229888A (hu) |
KR (1) | KR19980071443A (hu) |
CN (1) | CN1197077A (hu) |
AR (1) | AR011446A1 (hu) |
AU (1) | AU735514B2 (hu) |
BR (1) | BR9800641A (hu) |
CA (1) | CA2224123A1 (hu) |
CZ (1) | CZ46098A3 (hu) |
HU (1) | HUP9800329A3 (hu) |
PL (1) | PL324919A1 (hu) |
TR (1) | TR199800237A2 (hu) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9724829D0 (en) * | 1997-11-21 | 1998-01-21 | Muller Rolf | Transcription factor |
HUP9900956A2 (hu) | 1998-04-09 | 2002-04-29 | Aventis Pharma Deutschland Gmbh. | Egyláncú, több antigéntkötőhely kialakítására képes molekulák, előállításuk és alkalmazásuk |
US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
AU2003241409A1 (en) * | 2003-05-12 | 2005-01-21 | Potomac Pharmaceuticals, Inc. | Gene expression suppression agents |
WO2005033284A2 (en) * | 2003-10-01 | 2005-04-14 | The Regents Of The University Of California | Compositions and methods for gene expression |
WO2005085455A1 (en) * | 2004-03-09 | 2005-09-15 | Kam Man Hui | Compositions and methods for treating disease |
HUE026303T2 (hu) * | 2005-07-25 | 2016-06-28 | Emergent Product Dev Seattle | B-sejt csökkentés CD37-specifikus és CD20-specifikus kapcsoló molekulák alkalmazásával |
EP2418223A3 (en) | 2006-06-12 | 2013-01-16 | Emergent Product Development Seattle, LLC | Single-chain multivalent binding proteins with effector function |
BRPI0814060A2 (pt) * | 2007-07-06 | 2015-01-06 | Trubion Pharmaceuticals Inc | Peptídeos ligantes tendo um domínio de ligação específico disposto em c-terminal |
DK2132228T3 (da) * | 2008-04-11 | 2011-10-10 | Emergent Product Dev Seattle | CD37-immunterapeutisk middel og kombination med bifunktionelt kemoterapeutisk middel deraf |
EP2550362B1 (en) | 2010-03-25 | 2017-01-04 | Oregon Health&Science University | Cmv glycoproteins and recombinant vectors |
CA2832109C (en) | 2011-06-10 | 2021-07-06 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
EP2679596B1 (en) | 2012-06-27 | 2017-04-12 | International Aids Vaccine Initiative | HIV-1 env glycoprotein variant |
US20150065381A1 (en) | 2013-09-05 | 2015-03-05 | International Aids Vaccine Initiative | Methods of identifying novel hiv-1 immunogens |
EP2873423B1 (en) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3069730A3 (en) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
EP3072901A1 (en) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Soluble hiv-1 envelope glycoprotein trimers |
CN108367004B (zh) | 2015-09-21 | 2022-09-13 | 阿帕特夫研究和发展有限公司 | Cd3结合多肽 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU1552995A (en) * | 1993-12-17 | 1995-07-03 | Spinal Cord Society | Method for inducing dna synthesis in neurons |
GB9506466D0 (en) | 1994-08-26 | 1995-05-17 | Prolifix Ltd | Cell cycle regulated repressor and dna element |
WO1996006938A1 (de) * | 1994-08-26 | 1996-03-07 | Hoechst Aktiengesellschaft | Gentherapeutische behandlung von gefässerkrankungen durch einen zellspezifischen, zellzyklusabhängigen wirkstoff |
DE19524720A1 (de) | 1995-07-12 | 1997-01-16 | Hoechst Ag | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinasn-3" |
GB9502873D0 (en) * | 1995-02-14 | 1995-04-05 | Medical Res Council | Transcription factor |
FR2735789B1 (fr) * | 1995-06-23 | 1997-07-25 | Centre Nat Rech Scient | Adenovirus recombinants, leur utilisation pour preparer des aav, lignee cellulaire complementaire et compositions pharmaceutiques les contenant |
DE19605279A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Zielzellspezifische Vektoren für die Einschleusung von Genen in Zellen, Arzneimittel enthaltend derartige Vektoren und deren Verwendung |
DE19605274A1 (de) | 1996-02-13 | 1997-08-14 | Hoechst Ag | Nukleinsäurekonstrukte für die zellzyklusregulierte Expression von Genen, derartige Konstrukte enthaltende Zellen sowie deren Verwendung zur Herstellung von Heilmitteln |
-
1997
- 1997-02-18 EP EP97102547A patent/EP0860445A1/en not_active Withdrawn
-
1998
- 1998-02-16 CZ CZ98460A patent/CZ46098A3/cs unknown
- 1998-02-16 AU AU55398/98A patent/AU735514B2/en not_active Ceased
- 1998-02-16 TR TR1998/00237A patent/TR199800237A2/xx unknown
- 1998-02-16 AR ARP980100683A patent/AR011446A1/es unknown
- 1998-02-17 HU HU9800329A patent/HUP9800329A3/hu unknown
- 1998-02-17 CN CN98106925A patent/CN1197077A/zh active Pending
- 1998-02-17 BR BR9800641-0A patent/BR9800641A/pt not_active IP Right Cessation
- 1998-02-18 US US09/025,343 patent/US6380170B1/en not_active Expired - Fee Related
- 1998-02-18 CA CA002224123A patent/CA2224123A1/en not_active Abandoned
- 1998-02-18 JP JP10036408A patent/JPH10229888A/ja active Pending
- 1998-02-18 PL PL98324919A patent/PL324919A1/xx not_active Application Discontinuation
- 1998-02-18 KR KR1019980004878A patent/KR19980071443A/ko not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2224123A1 (en) | 1998-08-18 |
AU5539898A (en) | 1998-08-20 |
AU735514B2 (en) | 2001-07-12 |
JPH10229888A (ja) | 1998-09-02 |
EP0860445A1 (en) | 1998-08-26 |
TR199800237A2 (xx) | 1998-09-21 |
CZ46098A3 (cs) | 1998-09-16 |
HUP9800329A3 (en) | 2001-10-29 |
AR011446A1 (es) | 2000-08-16 |
BR9800641A (pt) | 1999-12-07 |
KR19980071443A (ko) | 1998-10-26 |
HU9800329D0 (en) | 1998-04-28 |
PL324919A1 (en) | 1998-08-31 |
US6380170B1 (en) | 2002-04-30 |
CN1197077A (zh) | 1998-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9800329A2 (hu) | Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására | |
AU2002339458A1 (en) | Sirna knockout assay method and constructs | |
Nakamura et al. | Messenger ribonucleic acid of the lipoprotein of the Escherichia coli outer membrane. II. The complete nucleotide sequence. | |
BR0010725A (pt) | Expressão e exportação de proteìnas de interferon-alfa como proteìnas de fusão de fc | |
WO2002031134A3 (en) | Novel serine protease genes related to dppiv | |
ATE192500T1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
BR8200191A (pt) | Celula viva renina preprorrenina prorrenina processo para obter expressao de preporrenina prorrenina e renina gene de prorrenina preprorrenina e renina e coli material dna recombinador saccharomyces cerevisiae polipetidio processo para exprimir um gene | |
WO1997014809A3 (en) | Novel expression vectors and methods of use | |
ATE435232T1 (de) | Nukleotid- und proteinsequenzen von nogo-genen und darauf beruhende methoden | |
MXPA04004634A (es) | Expresion policistronica de anticuerpos. | |
LTIP828A (en) | Nucleic acid fragment which codes for human proapolipoprotein a-1 | |
PT917571E (pt) | Gene relacionado com agouti | |
HU212592B (en) | Method for producing antibodies genetechnologically | |
HUP9702377A2 (hu) | Önfelerősítő, gyógyszeres úton szabályozható expressziós rendszerek | |
HUP0001817A2 (hu) | Chlorella víruspromóterek | |
ATE542913T1 (de) | Promotorvarianten zur expression von genen in einer pilzzelle | |
WO2001019966A3 (en) | Isolation of muscle-derived stem cells and uses therefor | |
FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
ATE86662T1 (de) | Verfahren und nukleinsaeure zur herstellung von lecithin: cholestrinacyltransferase. | |
SE0102204D0 (sv) | New method | |
Fournier et al. | Differential transcription of multiple copies of a silk worm gene encoding tRNA1Gly | |
DE3877136D1 (de) | Rekombinantes histidinreiches protein von plasmodium falciparum, seine herstellung und verwendung. | |
DE3688549D1 (de) | Verfahren zur expression von genen in hefe, dns-fragmente und plasmide die letztere fragmente enthalten und zur durchfuehrung des verfahrens verwendet werden. | |
HUP0001809A2 (hu) | Fotoszenzibilizálókkal szembeni rezisztenciát kódoló izolált gének és fehérjék | |
Ko | PRODUCTION AND CHARACTERIZATION OF THE ADENOVIRUS 2 EARLY REGION 1A AND 1B PROTEINS IN ESCHERICHIA COLI (COMPLEMENTARY-DNA CLONING, EIA/EIB BINDING ACTIVITY, EXPRESSION VECTORS) |